Pharma drug makers companies are consolidated now due to USFDA strict rules and standard to be followed and strictly maintained, which is actually good for this industries.
I think this companies now has already understood consequences if rules/standard are not followed and put strict policy within organization to follow the same.
This is called transition phase, look after high quality pharma companies which can bear such transition phase without any external cost and hit the glory in upcoming dates.